Authors:
Fevig, JM
Pinto, DJ
Han, Q
Quan, ML
Pruitt, JR
Jacobson, IC
Galemmo, RA
Wang, SA
Orwat, MJ
Bostrom, LL
Knabb, RM
Wong, PC
Lam, PYS
Wexler, RR
Citation: Jm. Fevig et al., Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core, BIOORG MED, 11(5), 2001, pp. 641-645
Authors:
Pinto, DJP
Orwat, MJ
Wang, SG
Fevig, JM
Quan, ML
Amparo, E
Cacciola, J
Rossi, KA
Alexander, RS
Smallwood, AM
Luettgen, JM
Liang, L
Aungst, BJ
Wright, MR
Knabb, RM
Wong, PC
Wexler, RR
Lam, PYS
Citation: Djp. Pinto et al., Discovery of 1-[3-(aminomethyl)phenyl]-N-[3-fluoro-2 '- (methylsulfonyl)-[1,1 '-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa, J MED CHEM, 44(4), 2001, pp. 566-578
Citation: J. Cacciola et al., Synthesis and activity studies of conformationally restricted alpha-ketoamide factor Xa inhibitors, BIOORG MED, 10(11), 2000, pp. 1253-1256
Authors:
Fevig, JM
Buriak, J
Stouten, PFW
Knabb, RM
Lam, GN
Wong, PC
Wexler, RR
Citation: Jm. Fevig et al., Preparation of pyrrolidine and isoxazolidine benzamidines as potent inhibitors of coagulation factor Xa, BIOORG MED, 9(8), 1999, pp. 1195-1200
Authors:
Fevig, JM
Cacciola, J
Alexander, RS
Knabb, RM
Lam, GN
Wong, PC
Wexler, RR
Citation: Jm. Fevig et al., Preparation of meta-amidino-N,N-disubstituted anilines as potent inhibitors of coagulation factor Xa, BIOORG MED, 8(22), 1998, pp. 3143-3148
Authors:
Strickland, CL
Fevig, JM
Galemmo, RA
Wells, BL
Kettner, CA
Weber, PC
Citation: Cl. Strickland et al., Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding, ACT CRYST D, 54, 1998, pp. 1207-1215